Top Biotechnology companies in France by Total Assets

This ranking features the top 28 Biotechnology companies in France ranked by Total Assets, totaling a Total Assets of USD 161.13 B, for June 24, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in France has the highest Total Assets ?

The Biotechnology company in France with the highest Total Assets is Sanofi (Paris Stock Exchange: SAN.PA) at USD 137.51 B.
Which Biotechnology company in France has the lowest Total Assets ?

The Biotechnology company in France with the lowest Total Assets is Advicenne S.A. (Paris Stock Exchange: ALDVI.PA) at USD 13.69 M.

What are the top 10 Biotechnology companies in France by Total Assets ?

The top 10 Biotechnology companies in France by Total Assets are Sanofi, Sartorius Stedim Biotech S.A., Ipsen S.A., bioMérieux S.A., Cellectis S.A., Biosynex SA, Eurobio Scientific SA, ABIVAX SA, Novacyt S.A. and Genfit S.A..
What are the bottom 10 Biotechnology companies in France by Total Assets ?

The bottom 10 Biotechnology companies in France by Total Assets are Advicenne S.A., ABIONYX Pharma SA, Valbiotis SA, Aelis Farma SA, Ikonisys S.A., Adocia SA, AB Science S.A., genOway SA, MedinCell S.A. and MaaT Pharma SA.